EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

EASIX Is an Accurate and Easily Available Prognostic Score in Critically Ill Patients with Advanced Liver Disease

David Schult iD, Sebastian Rasch iD, Roland M Schmid, Tobias Lahmer, Ulrich Mayr

Journal of Clinical Medicine · 28.03.2023 · 12 (7) · 2553

DOI: 10.3390/jcm12072553 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 28.03.2023. Verfasst von David Schult und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medizinische Klinik und Poliklinik II, Klinikum rechts der Isar, Technische Universität München, Ismaninger Straße 22, D-81675 München, Germany. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute-on-chronic liver failure (ACLF) is associated with high mortality. Objective prognostic scores are important for treatment decisions. EASIX (Endothelial Activation and Stress Index) is a simple biomarker consisting of LDH, platelets, and creatinine, reflecting endothelial dysfunction after allogeneic stem cell transplantation. Considering endothelial dysfunction in the pathogenesis of ACLF, this study aimed to test the discriminative ability of EASIX in advanced liver disease. We retrospectively analysed the prognostic potential of EASIX to predict 28-day and 3-month mortality in a total of 188 liver cirrhotic patients requiring treatment at the intensive care unit. We evaluated the ability of EASIX to rule out early infections and predict the need for hemodialysis. EASIX performed moderately better than established scores in predicting 28-day mortality (AUC = 0.771) and was nearly equivalent (AUC = 0.791) to SOFA and APACHE-II in the prediction of 3-month mortality. Importantly, EASIX showed better diagnostic potential in ruling out clinically apparent infections than common proinflammatory markers (AUC = 0.861, p < 0.001) and showed suitable accuracy in predicting the need for hemodialysis (AUC = 0.833). EASIX is an accurate, objective and easily assessable biomarker for predicting mortality and complications in patients with advanced liver disease.

Schlagwörter

Stichwörter der Autor:innen

EASIXacute-on-chronic liver failureendothelial dysfunctionintensive care unitliver cirrhosis

Autor:innen und Institutionen

  • Medizinische Klinik und Poliklinik II, Klinikum rechts der Isar, Technische Universität München, Ismaninger Straße 22, D-81675 München, Germany.

ORCID-Profile: David Schult, Sebastian Rasch

Zitieren

APA

Schult, D., Rasch, S., Schmid, R. M., Lahmer, T., & Mayr, U. (2023). EASIX Is an Accurate and Easily Available Prognostic Score in Critically Ill Patients with Advanced Liver Disease. Journal of Clinical Medicine, 12(7), 2553. https://doi.org/10.3390/jcm12072553

Vancouver

Schult D, Rasch S, Schmid RM, Lahmer T, Mayr U. EASIX Is an Accurate and Easily Available Prognostic Score in Critically Ill Patients with Advanced Liver Disease. Journal of Clinical Medicine. 2023;12(7):2553. doi:10.3390/jcm12072553

BibTeX
@article{Schult2023,
  author = {Schult, David and Rasch, Sebastian and Schmid, Roland M and Lahmer, Tobias and Mayr, Ulrich},
  title = {EASIX Is an Accurate and Easily Available Prognostic Score in Critically Ill Patients with Advanced Liver Disease},
  journal = {Journal of Clinical Medicine},
  year = {2023},
  volume = {12},
  number = {7},
  pages = {2553},
  doi = {10.3390/jcm12072553}
}
Kostenlos starten →